Effect of administering calcium carbonate to treat secondary hyperparathyroidism in nondialyzed patients with chronic renal failure.

Abstract

We administered calcium carbonate orally to determine its safety and efficacy in treating nondialyzed patients with mild to moderate renal failure and secondary hyperparathyroidism. Twenty patients with chronic renal failure (creatinine clearance levels ranging from 7.9 to 42.7 mL/min) participated in this study. After a 6-month control period, 3 g calcium… (More)

Topics

Cite this paper

@article{Tsukamoto1995EffectOA, title={Effect of administering calcium carbonate to treat secondary hyperparathyroidism in nondialyzed patients with chronic renal failure.}, author={Yasuhiro Tsukamoto and Rika Moriya and Yasushi Nagaba and Toshibumi Morishita and I Izumida and Minoru Okubo}, journal={American journal of kidney diseases : the official journal of the National Kidney Foundation}, year={1995}, volume={25 6}, pages={879-86} }